Literature DB >> 23142313

Insights into the impact of phenolic residue incorporation at each position along secretin for receptor binding and biological activity.

Maoqing Dong1, Delia I Pinon, Laurence J Miller.   

Abstract

Understanding of the structural importance of each position along a peptide ligand can provide important insights into the molecular basis for its receptor binding and biological activity. This has typically been evaluated using serial replacement of each natural residue with an alanine. In the current report, we have further complemented alanine scanning data with the serial replacement of each residue within secretin-27, the natural ligand for the prototypic class B G protein-coupled secretin receptor, using a photolabile phenolic residue. This not only provided the opportunity to probe spatial approximations between positions along a docked ligand with its receptor, but also provided structure-activity insights when compared with tolerance for alanine replacement of the same residues. The pattern of sensitivity to phenolic residue replacement was periodic within the carboxyl-terminal region of this peptide ligand, corresponding with alanine replacements in that region. This was supportive of the alpha-helical conformation of the peptide in that region and its docking within a groove in the receptor amino-terminal domain. In contrast, the pattern of sensitivity to phenolic residue replacement was almost continuous in the amino-terminal region of this peptide ligand, again similar to alanine replacements, however, there were key positions in which either the phenolic residue or alanine was differentially preferred. This provided insights into the receptor environment of the portion of this ligand most critical for its biological activity. As the structure of the intact receptor is elucidated, these data will provide a guide for ligand docking to the core domain and to help clarify the molecular basis of receptor activation.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23142313      PMCID: PMC3534899          DOI: 10.1016/j.regpep.2012.10.001

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  30 in total

1.  Dual contacts between peptide agonist ligands and the secretin receptor directly established by photoaffinity labeling.

Authors:  M Dong; Y Wang; L J Miller
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

2.  Spatial approximation between the amino terminus of a peptide agonist and the top of the sixth transmembrane segment of the secretin receptor.

Authors:  Maoqing Dong; Zhijun Li; Delia I Pinon; Terry P Lybrand; Laurence J Miller
Journal:  J Biol Chem       Date:  2003-10-30       Impact factor: 5.157

3.  Spatial approximation between a photolabile residue in position 13 of secretin and the amino terminus of the secretin receptor.

Authors:  Mengwei Zang; Maoqing Dong; Delia I Pinon; Xi-Qin Ding; Elizabeth M Hadac; Zhijun Li; Terry P Lybrand; Laurence J Miller
Journal:  Mol Pharmacol       Date:  2003-05       Impact factor: 4.436

4.  Elucidation of vasoactive intestinal peptide pharmacophore for VPAC(1) receptors in human, rat, and guinea pig.

Authors:  Hisato Igarashi; Tetsuhide Ito; Wei Hou; Samuel A Mantey; Tapas K Pradhan; Charles D Ulrich; Simon J Hocart; David H Coy; Robert T Jensen
Journal:  J Pharmacol Exp Ther       Date:  2002-04       Impact factor: 4.030

5.  Development of a biologically active secretin analogue incorporating a radioiodinatable photolabile p-(4-hydroxybenzoyl)phenylalanine in position 10.

Authors:  Maoqing Dong; Delia I Pinon; Laurence J Miller
Journal:  Regul Pept       Date:  2002-11-15

6.  Interaction among four residues distributed through the secretin pharmacophore and a focused region of the secretin receptor amino terminus.

Authors:  Maoqing Dong; Mengwei Zang; Delia I Pinon; Zhijun Li; Terry P Lybrand; Laurence J Miller
Journal:  Mol Endocrinol       Date:  2002-11

7.  Identification of key residues for interaction of vasoactive intestinal peptide with human VPAC1 and VPAC2 receptors and development of a highly selective VPAC1 receptor agonist. Alanine scanning and molecular modeling of the peptide.

Authors:  P Nicole; L Lins; C Rouyer-Fessard; C Drouot; P Fulcrand; A Thomas; A Couvineau; J Martinez; R Brasseur; M Laburthe
Journal:  J Biol Chem       Date:  2000-08-04       Impact factor: 5.157

8.  Elucidation of the vasoactive intestinal peptide pharmacophore for VPAC(2) receptors in human and rat and comparison to the pharmacophore for VPAC(1) receptors.

Authors:  Hisato Igarashi; Tetsuhide Ito; Tapas K Pradhan; Samuel A Mantey; Wei Hou; David H Coy; Robert T Jensen
Journal:  J Pharmacol Exp Ther       Date:  2002-11       Impact factor: 4.030

Review 9.  International Union of Pharmacology. XXXV. The glucagon receptor family.

Authors:  Kelly E Mayo; Laurence J Miller; Dominique Bataille; Stéphane Dalle; Burkhard Göke; Bernard Thorens; Daniel J Drucker
Journal:  Pharmacol Rev       Date:  2003-03       Impact factor: 25.468

10.  Spatial approximation between two residues in the mid-region of secretin and the amino terminus of its receptor. Incorporation of seven sets of such constraints into a three-dimensional model of the agonist-bound secretin receptor.

Authors:  Maoqing Dong; Zhijun Li; Mengwei Zang; Delia I Pinon; Terry P Lybrand; Laurence J Miller
Journal:  J Biol Chem       Date:  2003-09-18       Impact factor: 5.157

View more
  3 in total

1.  Use of Cysteine Trapping to Map Spatial Approximations between Residues Contributing to the Helix N-capping Motif of Secretin and Distinct Residues within Each of the Extracellular Loops of Its Receptor.

Authors:  Maoqing Dong; Polo C-H Lam; Andrew Orry; Patrick M Sexton; Arthur Christopoulos; Ruben Abagyan; Laurence J Miller
Journal:  J Biol Chem       Date:  2016-01-06       Impact factor: 5.157

Review 2.  Transmembrane signal transduction by peptide hormones via family B G protein-coupled receptors.

Authors:  Kelly J Culhane; Yuting Liu; Yingying Cai; Elsa C Y Yan
Journal:  Front Pharmacol       Date:  2015-11-05       Impact factor: 5.810

3.  Secretin Receptor as a Target in Gastrointestinal Cancer: Expression Analysis and Ligand Development.

Authors:  Anja Klussmeier; Stefan Aurich; Lars Niederstadt; Bertram Wiedenmann; Carsten Grötzinger
Journal:  Biomedicines       Date:  2022-02-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.